Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : BLUE crawled time : 13:30 save search
bluebird bio, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 28, 2024 to Discuss Your Rights - BLUE
Published: 2024-04-03 (Crawled : 13:30) - prnewswire.com
DKS | $199.29 0.38% 280K
|
Retail Trade
|
| O: -0.14%
H: 0.0%
C: 0.0%
INOD | $6.08 -1.3% 79K
|
Technology Services
|
| O: -0.89%
H: 9.55%
C: 6.27%
BLUE | $1.015 -1.46% 1.9M
|
Health Technology
|
| O: -2.48%
H: 3.39%
C: 0.0%
blue
Investors who lost money on DICK's Sporting Goods(DKS) should contact Levi & Korsinsky about pending Class Action - DKS
Published: 2024-04-03 (Crawled : 13:30) - prnewswire.com
DKS | $199.29 0.38% 280K
|
Retail Trade
|
| O: -0.14%
H: 0.0%
C: 0.0%
INOD | $6.08 -1.3% 79K
|
Technology Services
|
| O: -0.89%
H: 9.55%
C: 6.27%
BLUE | $1.015 -1.46% 1.9M
|
Health Technology
|
| O: -2.48%
H: 3.39%
C: 0.0%
Evolv Technologies Holdings, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EVLV
Published: 2024-04-03 (Crawled : 13:30) - prnewswire.com
EVLV | $3.98 460K
|
|
| O: -2.08%
H: 2.42%
C: -2.22%
DKS | $199.29 0.38% 280K
|
Retail Trade
|
| O: -0.14%
H: 0.0%
C: 0.0%
IESC | $120.07 0.27% 96K
|
Industrial Services
|
| O: -0.06%
H: 0.0%
C: 0.0%
BLUE | $1.015 -1.46% 1.9M
|
Health Technology
|
| O: -2.48%
H: 3.39%
C: 0.0%
SalioGen Therapeutics Appoints Jason F. Cole as Chief Executive Officer and Chairman of the Board of DirectorsBiotech industry veteran strengthens leadership team with decades of experience
Published: 2023-09-11 (Crawled : 13:30) - biospace.com/
BLUE | $1.015 -1.46% 1.9M
|
Health Technology
|
| O: -0.84%
H: 1.98%
C: 0.56%
decades therapeutics
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
Published: 2022-01-26 (Crawled : 13:30) - biospace.com/
TSVT | $4.835 -4.07% 450K
|
|
| O: 1.06%
H: 2.71%
C: -10.48%
NVS | $93.29 -1.19% 530K
|
Health Technology
|
| O: 0.66%
H: 0.26%
C: -1.01%
BLUE | $1.015 -1.46% 1.9M
|
Health Technology
|
| O: 1.29%
H: 5.03%
C: -1.78%
ADAP | $1.03 -1.91% 950K
|
Health Technology
|
| O: 1.75%
H: 3.78%
C: -3.09%
commercialization
bluebird bio to Present at the 40th Annual J.P. Morgan Healthcare Conference
Published: 2022-01-05 (Crawled : 13:30) - biospace.com/
BLUE | $1.015 -1.46% 1.9M
|
Health Technology
|
| O: -0.39%
H: 2.64%
C: -3.22%
health thc conference j.p. morgan healthcare conference
bluebird bio Announces Partial Clinical Hold for Patients Under 18 in Sickle Cell Gene Therapy Clinical Program
Published: 2021-12-20 (Crawled : 13:30) - biospace.com/
BLUE | $1.015 -1.46% 1.9M
|
Health Technology
|
| O: -9.24%
H: 27.28%
C: 26.75%
clinical hold gene therapy cel therapy
Gainers vs Losers
| 53% | 47% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
PRSO | $1.99 56.69% 52M
|
Manufacturing
PALI | $6.5 56.25% 22M
|
Manufacturing
JAGX | $0.1767 48.74% 430M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
DYNT | $0.52 40.39% 20M
|
Health Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
BSGM | $1.53 39.09% 2.6M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.